World of Showjumping

This week

Coming weeks

The calendar is being updated daily to the FEI list of cancelled events.

Emma Augier de Moussac releases statement regarding FEI suspension

Monday, 27 January 2020

Photo © Jenny Abrahamsson for World of Showjumping
Emma Augier de Moussac, here with Diva. Photo © Jenny Abrahamsson for World of Showjumping.

After being indefinitely suspended by the FEI for a positive test to hydrochlorothiazide*, Czech rider Emma Augier de Moussac now speaks out. 

In a statement, Augier de Moussac explains how she has traced the positive test back to a supplement that was marketed by the producer as being 100% natural. The full statement reads as follows:

"For an aesthetic reason I started to take for a month a food supplement described and sold as being 100% natural, as shown in the package leaflet, the packaging and the website. Multiple comments on different websites praise the fact that it was 100% natural and its effectiveness without any side effects. Following an anti-doping test carried out after a competition, a substance prohibited by anti-doping regulations appeared in the analyzes. Following these results, I immediately carried out a complete analysis of the products which I had used, by a certified laboratory, the results highlighted that: this product was in reality absolutely not 100% natural and that the product consumed contained the prohibited substance found during the inspection.

I accepted a temporary suspension pending the decision of the federation, however, only being a victim of the false advertising carried out by the seller of the food supplement I consumed." 

Augier de Moussac's suspension commenced on the 23rd of December 2019, side-lining the 29-year-old rider from competition.  


*Hydrochlorothiazide is a prohibited substance listed on the World Anti Doping Agency's prohibited substance's list under diuretics and masking agents


This photo has been added to your cart !

Your shopping cart »
This website is using cookies for statistics, site optimization and retargeting purposes. You consent to our cookies if you continue to use this website. Read more here.